Stay updated on Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial
Sign up to get notified when there's something new on the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page.

Latest updates to the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing v3.6.2, signaling a minor platform update; study content remains unchanged.SummaryDifference0.0%

- Check15 days agoChange DetectedThe page shows a revision tag update from v3.6.0 to v3.6.2, indicating a minor update to the site template or codebase rather than changes to the study details.SummaryDifference0.0%

- Check29 days agoChange DetectedRecruitment has ended, as the page now states no longer looking for participants. The update also adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment header along with a revision note for version 3.6.0.SummaryDifference0.3%

- Check36 days agoChange DetectedFooter revision updated from v3.5.4 to v3.5.5, indicating a newer page template version. This change does not modify the study details or visible content.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous v3.5.3. This indicates a minor update to the site's underlying system, with no visible changes to the study details.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page now shows the revision label as v3.5.3, indicating an updated build of the page.SummaryDifference0.0%

Stay in the know with updates to Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page.